The Era of Polypills in the Management of Cardiovascular Diseases: Are We There Yet?-Reference-Cited by-同舟云学术

The Era of Polypills in the Management of Cardiovascular Diseases: Are We There Yet?

Published:2022-04 Issue: Volume: Page:101233
ISSN:0146-2806
Container-title:Current Problems in Cardiology
language:en
Short-container-title:Current Problems in Cardiology

Author:

Khan Arsalan Aamir,Siddiqui Sarush Ahmed,Yasmin Farah,Abidi Syeda Mahnoor,Tariq Rabbia,Ahmed Hiba,Murtaza Noor,Jawed Fareeha,Lashkerwala Sehan Siraj,Moin Ariba,Shah Syed Muhammad Ismail,Ullah Irfan,Yousaf Zohaib,Faizan Muhammad,Shahid Muhammad Huzaifa^ORCID

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Reference110 articles.

1. World Health Organization. Health topics: cardiovascular diseases. See http://www. who. int/topics/cardiovascular_diseases/en/(last checked July 2012). 2013.

2. Pharmaceutical issues in the development of a polypill for the treatment of cardiovascular diseases;Kumar;Drug Discov Today Ther Strat,2008

3. A strategy to reduce cardiovascular disease by more than 80%;Wald;BMJ,2003

4. Benefits, challenges, and registerability of the polypill;Sleight;Eur Heart J,2006

5. The concept of the polypill in the prevention of cardiovascular disease;Wiley;Ann Glob Health,2014

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Extrusion-based 3D printing for development of complex capsular systems for advanced drug delivery;International Journal of Pharmaceutics;2024-09

2. Russian medical society expert consensus on arterial hypertension: use of fixed combinations in the treatment of patients with arterial hypertension;Systemic Hypertension;2024-03-25

3. In-lab synthesized turn-off fluorescence sensor for estimation of Gemigliptin and Rosuvastatin polypill appraised by Spider diagram, AGREE and whiteness metrics;Scientific Reports;2024-02-05

4. Redefining the polypill: pros and cons in cardiovascular precision medicine;Frontiers in Pharmacology;2023-09-19

5. The use of the CNIC-Polypill in real-life clinical practice: opportunities and challenges in patients at very high risk of atherosclerotic cardiovascular disease – expert panel meeting report;BMC Proceedings;2023-08-17